Related Experiment Video
Updated: Jul 1, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Targeted exosome-based nanoplatform for new-generation therapeutic strategies
Wenjing Yin1, Hongyin Ma1, Yang Qu1
1Stroke Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun 130021, People's Republic of China.
Exosomes, tiny vesicles, are promising for drug delivery due to their biocompatibility. Advanced bioengineering can enhance exosome-based nanoplatforms for targeted therapeutic applications.
Area of Science:
- Biotechnology
- Nanomedicine
- Cell Biology
Background:
- Exosomes are nanoscale vesicles involved in intercellular communication.
- Their inherent biocompatibility and low immunogenicity make them attractive for therapeutic applications.
- Exosomes can be engineered for targeted drug delivery, carrying various therapeutic cargoes.
Purpose of the Study:
- To review the properties, isolation, characterization, and biological functions of exosomes.
- To explore the potential of exosomes as drug delivery nanoplatforms.
- To discuss advancements in exosome engineering for targeted and stimuli-responsive drug delivery.
Main Methods:
- Literature review of exosome properties and functions.
- Analysis of exosome isolation and characterization techniques.
- Examination of genetic and chemical modification strategies for exosome-based delivery systems.
Main Results:
- Exosomes facilitate intercellular communication and signal transmission.
- Engineered exosomes demonstrate therapeutic potential in disease models.
- Stimuli-responsive exosome systems offer precise control over drug release.
Conclusions:
- Exosomes possess significant potential as biocompatible drug delivery nanoplatforms.
- Further integration of bioengineering and materials science is crucial for clinical translation.
- Optimizing exosome-based systems will accelerate their development for therapeutic applications.
More Related Videos
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Targeted Cancer Therapies
There are several types of targeted therapies against...